ZyVersa Therapeutics Inc (ZVSA)
3.55
-0.21
(-5.59%)
USD |
NASDAQ |
Jul 01, 13:49
ZyVersa Therapeutics Shareholders Equity (Quarterly): 11.22M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.22M |
| December 31, 2023 | 11.07M |
| September 30, 2023 | 19.70M |
| June 30, 2023 | 20.06M |
| March 31, 2023 | 97.10M |
| Date | Value |
|---|---|
| December 31, 2022 | 99.99M |
| September 30, 2022 | -11.80M |
| June 30, 2022 | -15.22M |
| December 31, 2021 | -12.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-15.22M
Minimum
Jun 2022
99.99M
Maximum
Dec 2022
24.40M
Average
11.22M
Median
Mar 2024
Shareholders Equity (Quarterly) Benchmarks
| OptiNose Inc | -99.22M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 24.86M |
| Theriva Biologics Inc | 34.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.65M |
| Total Liabilities (Quarterly) | 10.43M |